A prospective trial of tacrolimus (FK 506) in clinical heart transplantation: Intermediate-term results

Journal of Thoracic and Cardiovascular Surgery

Volumn 111, Issue 4, 1996, Pages 764-772

  Pham, S M ^a   Kormos, R L ^a   Hattler, B G ^a   Kawai, A ^a   Tsamandas, A C ^a   Demetris, A J ^a   Murali, S ^a   Fricker, F J ^a   Chang, H C ^a   Jain, A B ^a   Starzl, T E ^a   Hardesty, R L ^a   Griffith, B P ^a   Rose, E A ^a   Castaneda, A R ^a  

^a Division of Cardiothoracic Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; METHOTREXATE; METHYLPREDNISOLONE; OKT 3; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; HYPERKALEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; LYMPH NODE IRRADIATION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STEROID THERAPY; SURVIVAL;

EID: 0029874140     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(96)70336-7     Document Type: Article

References (32)

1. T Kino H Hataraka S Miyata FK506, a novel immunosuppression isolated from a streptomyces: immunosuppressive effect of FK506 in vitro J Antibiotics 40 1987 1256 1260
2. A Zeevi R Duquesnoy G Eiras Immunosuppressive effect of FK 506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A Transplant Proc 19 1987 40 44
3. JM Armitage RL Kormos J Fung TE Starzl The clinical trial of FK506 as primary and rescue immunosuppression in adult cardiac transplantation Transplant Proc 23 1992 3054 3057
4. FC Greiner J Luczkiw M Bergmann A whole blood FK506 assay for the IMx analyzer Transplant Proc 23 1991 2748 2749
5. RL Kormos JM Armitage JS Dummer Optimal perioperative immunosuppression in cardiac transplantation using rabbit antithymocyte globulin Transplantation 49 1990 306 311
6. RC Davis SR Cooperband JA Mannick Preparation and in vitro assay of effective and ineffective antithymocyte sera Surgery 66 1969 58 64
7. RM Bolman B Elick MT Olivari WS Ring CE Arentzen Improved immunosuppression for cardiac transplantation J Heart Transplant 4 1985 315 318
8. ME Billingham NRB Cary ME Hammond A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group J Heart Lung Transplant 9 1990 587 593
9. S Kusne JS Dummer N Singh Infection after liver transplantation: an analysis of 101 consecutive cases Medicine 67 1988 132
10. K Detre P Peduzzi The problem of attributing deaths of nonadherers: the VA coronary bypass experience Controlled Clin Trials 3 1982 355 364
11. P Peduzzi K Detre J Wittes T Holford Intent-to-treat analysis and the problem of crossovers J THORAC CARDIOVASC SURG 101 1991 481 487
12. BJ Wiener Statistical principles in experimental design 1971 : McGraw-Hill New York 196 201
13. B Rosner Fundamentals of biostatics 3rd ed 1990 : Duxbury Press Belmont, California 336 372
14. MS Tocci DA Matkovich KA Collier The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes J Immunol 143 1989 718 726
15. T Ochiai K Nakajima M Nagata Effect of a new immunosuppressive agent, FK506, on heterotopic cardiac allotransplantation in the rat Transplant Proc 19 1987 1284 1286
16. N Murase DG Kim S Todo Suppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short course therapy Transplantation 50 1990 1986 1989
17. N Murase DG Kim S Todo DV Cramer J Fung TE Starzl FK506 suppression of heart and liver allograft rejection. II. The induction of graft acceptance in rats Transplantation 50 1990 739 744
18. S Todo Y Ueda AJ Demetris Immunosuppression of canine, monkey, and baboon allografts by FK506 with special reference to synergism with other drugs and tolerance induction Surgery 104 1988 239 240
19. TE Starzl S Todo JJ Fung FK506 for liver, kidney, and pancreas transplantation Lancet 2 1989 1000 1004
20. S Todo JJ Fung A Tzakis Early trials with FK506 as primary treatment in liver transplantation Transplant Proc 22 1990 13 16
21. ML Jordan R Shapiro CA Vivas FK506 “rescue” for resistant rejection of renal allografts under primary cyclosporine immunosuppression Transplantation 57 1994 860 865
22. JM Armitage RL Kormos S Morita Clinical trial of FK506 immunosuppression in adult cardiac transplantation Ann Thorac Surg 54 1992 205 211
23. The U.S. Multicenter FK506 Liver Study Group A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation N Engl J Med 331 1994 1110 1115
24. The US Multicenter FK506 Study Group Prognostic factors for successful conversion from cyclosporine to FK506-based immunosuppressive therapy for refractory rejection after liver transplantation Transplant Proc 23 1993 2987 2990
25. European FK506 Multicentre Liver Study Group Randomized trial comparing tacrolimus (FK506) and cyclosporine in prevention of liver allograft rejection Lancet 344 1994 423 424
26. SM Pham JM Armitage RL Kormos Rescue therapy with FK-506 in cardiac transplantation Circulation 88 Suppl 1993 I94
27. LJ Swinnen M Costanzo-Nordin SG Fisher Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac transplant recipients N Engl J Med 323 1990 1723 1728
28. AB Jain JJ Fung S Todo One thousand consecutive primary orthotopic liver transplants under FK 506: survival and adverse events Transplant Proc 27 1995 1099 1104
29. US Multicenter Liver Study Group Comparing nephrotoxicity of FK506 and cyclosporine regimens after liver transplantation: preliminary results from US Multicenter Trial Transplant Proc 27 1995 1114 1116
30. KJ Berg O Forre F Bjerkhoel Side effects of cyclosporine A treatment in patients with rheumatoid arthritis Kidney Int 29 1986 1180 1187
31. JP Bantle KA Nath DE Sutherland JS Najarian TF Ferris Effects of cyclosporine on the renin-angiotensin-aldosterone system and potassium excretion in renal transplant recipients Arch Intern Med 145 1985 505 508
32. BP Griffith K Bando RL Hardesty A prospective randomized trial of FK506 versus cyclosporine after human pulmonary transplantation Transplantation 57 1994 848 851